Literature DB >> 10818444

Lipid phosphate phosphatase-1 in the regulation of lysophosphatidate signaling.

J Xu1, Q X Zhang, C Pilquil, L G Berthiaume, D W Waggoner, D N Brindley.   

Abstract

Mammalian lipid phosphate phosphatases (LPPs, or Type 2 phosphatidate phosphohydrolases) constitute a family of enzymes that belongs to a phosphatase superfamily. The LPPs dephosphorylate a variety of bioactive lipid phosphates including phosphatidate, lysophosphatidate, sphingosine 1-phosphate, and ceramide 1-phosphate. Mouse LPP-1 was stably expressed in rat2 fibroblasts to determine its structural and functional properties. Transduced cells showed increased dephosphorylation of exogenous lysophosphatidate. This result is compatible with mutational studies that show the active site of LPP-1 to be located on the external surface of the plasma membrane. Elevated LPP-1 activity attenuated the ability of lysophosphatidate to stimulate mitogen-activated protein kinase (ERK1 and 2) activities and DNA synthesis. It is concluded that one function of LPP-1 is to dephosphorylate exogenous lysophosphatidate, thereby attenuating cell signaling through endothelial cell differentiation gene (EDG) receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818444     DOI: 10.1111/j.1749-6632.2000.tb06540.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Pulmonary lipid phosphate phosphohydrolase in plasma membrane signalling platforms.

Authors:  M Nanjundan; F Possmayer
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

2.  Expression of ectolipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes. Involvement in the control of lysophosphatidic acid production.

Authors:  Marie Francoise Simon; Astrid Rey; Isabelle Castan-Laurel; Sandra Grés; David Sibrac; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

3.  Delta-catenin/NPRAP (neural plakophilin-related armadillo repeat protein) interacts with and activates sphingosine kinase 1.

Authors:  Toshitada Fujita; Taro Okada; Shun Hayashi; Saleem Jahangeer; Noriko Miwa; Shun-ichi Nakamura
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

4.  A lysophosphatidic acid analogue is revealed as a potent inhibitor of phosphatidylcholine synthesis, inducing apoptosis.

Authors:  Geneviéve Gueguen; Virginie Granci; Pierre Rogalle; Fabienne Briand-Mésange; Michéle Wilson; Alain Klaébé; François Tercé; Hugues Chap; Jean-Pierre Salles; Marie-Françoise Simon; Frédérique Gaits
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

5.  Lysophosphatidic acid counteracts glucagon-induced hepatocyte glucose production via STAT3.

Authors:  Evan P Taddeo; Stefan R Hargett; Sujoy Lahiri; Marin E Nelson; Jason A Liao; Chien Li; Jill K Slack-Davis; Jose L Tomsig; Kevin R Lynch; Zhen Yan; Thurl E Harris; Kyle L Hoehn
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

Review 6.  Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside.

Authors:  Yan Xu
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.